Employers have long realized the various impacts that chronic diseases can have on individuals within their workforce – both from an HR perspective and a medical-cost perspective. And while the pandemic has both exacerbated and underscored the importance of chronic condition management, many HR and benefits teams were forced to hit the pause button or say ‘not yet’ with some of the innovations and launches that may have been planned and re-prioritize where focus needs to lie. In this webinar series, we discuss the chronic conditions that most impact employers from a cost and productivity perspective, examine current thinking in regards to benefit offerings in this new Covid-world, and share insights and recommendations to best address the impact of chronic conditions on the workforce.
Greater Philadelphia Business Coalition on Health (GPBCH)
Established in 2012, the Greater Philadelphia Business Coalition on Health (GPBCH) is a membership organization open to any employer that is corporately based or that has a significantly employed population in our service area. The Coalition’s service area includes the Philadelphia five-county region (Philadelphia, Bucks, Montgomery, Chester, and Delaware Counties), the State of Delaware, and Southern New Jersey (Camden, Burlington, Gloucester, Salem, Cumberland, Atlantic and Cape May Counties). GPBCH also offers affiliate memberships to organizations that do not participate as employers but have an interest in supporting GPBCH’s mission.
Our mission is to increase the value of health benefit spending for employer members, by improving workforce and community health, increasing healthcare quality and safety, and reducing health care costs. The Coalition represents employer interests in working with health plans, health care providers, benefits consultants, suppliers and other system stakeholders to address population health priorities and to ensure that when health care is needed it is accessible, affordable, high-quality, and safe.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on www.pfizer.com and follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Employer Perspectives: Strategies and Approaches to Disease Prevention, Monitoring, and Management in 2021
This panel of HR and Benefits executives shares their insights and experience in helping their employees affected by chronic conditions achieve better health outcomes – knowing healthy employees are more productive employees – while lowering health care costs for their organization through the prevention and management of chronic diseases. Knowing that the pandemic has both exacerbated and underscored the importance of chronic condition management, hear about different considerations, approaches, and strategies being evaluated in 2021.
Understand the risks those with chronic diseases face during the pandemic and steps employers can take now to help
Discuss various discovery methods for employees to better understand their status with disease and what their own data could tell them to become better stewards of their own health
Identify the types of programs that have traditionally led to the most impactful results – from cost-savings to employee well-being and satisfaction – and what may be the same or different during, and after, the pandemic
Examine best practices to implementing disease prevention, monitoring, and management programs as a part of your benefit offerings
Learn strategies to overcome common engagement struggles, such as providing incentives to drive behavior change and/or disincentives for inaction
Neil Goldfarb President and CEO Greater Philadelphia Business Coalition on Health View Bio
President and CEO Greater Philadelphia Business Coalition on Health
Mr. Neil Goldfarb is President and CEO of the Greater Philadelphia Business Coalition on Health (GPBCH, www.gpbch.org), which brings together employers in Southeastern Pennsylvania, Delaware, and Southern New Jersey who are committed to improving the health of their employees and the safety, quality and value delivered by the healthcare system. GPBCH represents over 1.5 million covered lives nationally. Before founding GPBCH in 2012, Mr. Goldfarb spent over 30 years in healthcare research, quality improvement, and management positions. As Associate Dean for Research in the Jefferson College of Population Health, he was responsible for leading the school’s research agenda, while concurrently serving as Director of Ambulatory Care Performance Improvement for Thomas Jefferson University’s faculty practice plan. His previous positions include Executive Director of a quality improvement consulting firm, and Vice President of Health Services for the Philadelphia region’s first Medicaid managed care plan. Mr. Goldfarb has authored over 60 articles in the peer-reviewed literature. Mr. Goldfarb is active in the governance of the National Alliance of Healthcare Purchaser Coalitions, and founding co-Director of the College for Value-based Purchasing of Health Benefits.
David Hines Executive Director, Employee Benefits Metro Nashville Public Schools View Bio
Kirsten John Vice President, Health Benefit Manager TD Bank View Bio
Gina Ross Murdoch President and CEO Multiple Sclerosis Association of America (MSAA) View Bio
Director, Benefits AT&T
Benjamin Hagan, first and foremost, is a father of two children, Annie (age 8) and Everett (age 5). He is also an avid runner and cyclist. Professionally, Ben is a Director, Benefits at AT&T. His team has responsibility for governance and compliance for global benefits and provides governance oversight for all suppliers across human resources. Previously he had responsibilities at AT&T that included contracting, implementation, and vendor management of medical, Rx and behavioral health benefits vendors and solutions for the over 1 million employees and retirees and their dependents that AT&T covers under its health and welfare programs. He has also experience creating the strategic designs of the health and welfare plan offerings, including changing and enhancing current offerings and researching and recommending new solutions and vendor partners.
Prior to AT&T, Ben was a Principal at Mercer for two years, with a focus on retirement plan consulting. There he managed a book of business that included client with pension and retiree medical plans ranging in size from tens of billions of dollars to millions of dollars. Additionally, he worked at Willis Towers Watson, prior to the Willis merger, for 11 years with a similar focus on pension and retiree medical plan consulting and book of business management. Though these consulting roles, he helped clients through a range of consulting issues including plan design, termination and risk transfer. He also facilitated corporate trainings as well as managed employees. He also served as a technical resource for his peers, a mentor, and a sales initiative leader.
He has a Masters in Business Administration, is a Fellow of the Society of Actuaries, and is an Enrolled Actuary. He did his undergraduate work at the University of Texas concluding with a mathematics degree with an actuarial science focus.
Executive Director, Employee Benefits Metro Nashville Public Schools
David’s career started at Blue Cross Blue Shield of Tennessee in claim’s management. He went on to serve as the Director of Operations for the State of Tennessee Employee Health Plans; Benefit Manager for Nissan Motor Manufacturing; benefits consultant; Insurance Director for Rutherford County, TN and now as Executive Director of Benefits for Metro Nashville Public Schools (MNPS).
While at MNPS he established a network of primary care clinics to serve their employees, retirees and their dependents. These clinics, staffed by Family Nurse Practitioners are Medical Homes and serve as the main conduit for medical interventions with our covered population. In 2017, he opened MNPS’ first integrated health and wellness facility, combining primary care, behavioral health, health coaching, fitness, physical therapy, chiropractic, acupuncture and pharmacy. This facility also includes a café and conference area and is designed to be a community center for educators, assisting them to develop professionally and personally. In addition, to help drive individual and group health improvements, he implemented a data warehouse that combines medical, pharmacy, dental and vision claims, medical records, payroll, health risk assessments and evaluation data.
Recently David was recognized by Employee Benefit News with the Benny Award for Benefits Leadership in Healthcare. Also Resulting from their work in improving population health, the MNPS team has earned numerous recognitions including: Health Value Award; C. Everett Koop National Health Award (honorable mention); American Heart Association Gold Workplace Achievement; Cigna Well Being Award and others.
David serves on the boards of Healthcare21, the State and Local Government Benefit Association and the National Association of Worksite Health Centers.
Vice President, Health Benefit Manager TD Bank
Gina Ross Murdoch
Gina Ross Murdoch
President and CEO Multiple Sclerosis Association of America (MSAA)
Gina Ross Murdoch is a seasoned executive with over 20 years of non-profit experience. Currently, she serves as President and CEO of the Multiple Sclerosis Association of America (MSAA), a national nonprofit organization dedicated to improving lives today for the MS community through education, direct impact and empowerment. Her career includes leadership positions with the Leukemia and Lymphoma Society, the American Diabetes Association and the National Multiple Sclerosis Society leading explosive growth initiatives and ground-breaking strategic projects. Ms. Murdoch currently also serves as Treasurer of the Multiple Sclerosis Coalition (MSC), a group of nine separate organizations dedicated to supporting the MS community. She recently co-chaired the first ever national patient program, the MS Summit, engaging all MSC member organizations into a single initiative. Ms. Murdoch is a Board Member for the Greater Philadelphia Business Coalition on Health and speaks across the country on critical healthcare topics such as co-pay accumulators, employment issues surrounding living with a chronic disease and the unique journey of the MS patient.
An active member of the community, Ms. Murdoch has held several elected positions in her town and volunteers for her college alma mater, Drew University, as a student mentor.
1:00 – 2:00 pm
Evaluate the Impact of Osteoarthritis on Employers
Osteoarthritis (OA), the most common form of arthritis, affects more than 32.5 million US adults, according to the CDC. OA can cause pain, stiffness, and swelling, and usually develops slowly, but gets worse over time, the CDC continues, yet there is no cure. Since OA is more prevalent in the working age population, and a significant portion of individuals with OA have a moderate to severe condition, OA impacts workers’ productivity, as well as an organization’s direct health care costs, and disability. This panel examines why employers and other plan sponsors should be aware of the impact of osteoarthritis (OA) on their workforce, and considerations those charged with managing employee benefits should take into account.
Gain a better understanding of disease, such as what OA is, what causes OA, and the risk factors that may lead to OA
Examine the effects OA can have on workers – From productivity, to absenteeism, and more
Discuss the current options available for managing the pain of OA – Nonpharmacologic, pharmacotherapy, and surgery
Consider the effectiveness, appropriateness, and/or tolerability of current options and where unmet needs may still exist
Identify the key considerations HR and benefits teams should take into account when evaluating the impact of OE on their business and workforce
Brian Gifford, PhD Director, Research and Analytics Integrated Benefits Institute View Bio
Heather Sell, PharmD, BCPS Director, National Employer Medical Outcomes Specialist Pfizer View Bio
Tom Sondergeld Vice President, Enterprise Growth Strategy Carrot View Bio
Brian Gifford, PhD
Director, Research and Analytics Integrated Benefits Institute
Brian Gifford is the Director of Research and Analytics at the Integrated Benefits Institute.
Brian joined IBI in September 2008 and is responsible for a variety of research and analytic programs focused on the investment value of a healthy, high-performing workforce. Brian came to IBI from the RAND Corporation, where his research focused primarily on workforce recruitment, training, performance and retention. Prior to RAND, he was a postdoctoral fellow in the Robert Wood Johnson Foundation’s Scholars in Health Policy Research Program at the University of California, Berkeley. He has additional expertise in the sociology of organizations.
He received his bachelor’s degree in sociology from the University of California, Berkeley, and his Ph.D. in sociology from New York University. His Ph.D. dissertation on institutional determinants of public social welfare spending received the American Sociological Association’s annual Dissertation Award in 2004.
Heather Sell, PharmD, BCPS
Director, National Employer Medical Outcomes Specialist Pfizer
Dr. Sell is a Medical Outcomes Specialist for Pfizer Pharmaceuticals. She collaborates with employer stakeholders on population health initiatives by providing clinical education and supporting real world clinical and pharmaco-economic analyses.
Dr. Sell earned her Bachelor of Science and Doctor of Pharmacy degrees at Purdue University. Her post-doctorate training included a Pharmacy Practice Residency at Rush Medical Center in Chicago, followed by a Specialized Residency in Drug Policy and Pharmacoeconomics at the University of Wisconsin. Before joining Pfizer, she served as the Clinical Coordinator and Pharmacy Practice Residency Director at Mercy Hospital in Chicago, Director of Clinical Consulting for Broadlane, and held academic appointments at the University of Florida and Purdue University. She is Board Certified in Pharmacotherapy and holds certifications in Real World Evidence Analysis by the University of Texas and Tobacco Cessation from the University of Arizona.
Vice President, Enterprise Growth Strategy Carrot
Tom Sondergeld is a revolutionary global executive with proven success transforming the program structure, strategy, and distribution mechanisms with operational excellence at Walgreens, a top 50 employer in the world. In his current role, Tom is the VP Enterprise Growth Strategy at Carrot Co and their Pivot Tobacco Cessation program. Broadly networked to the nation’s largest insurance/TPA organizations, employer coalitions (EHIR, NBGH, HTA), large and mid-sized employers, and healthcare solution innovators. A financially astute leader that has consistently demonstrated the ability to save hundreds of millions of dollars while avoiding increased member costs. Known for boosting the ROI of innovative and cutting-edge solutions. A leader not afraid to step into new space and lead.